Muraymycin Nucleoside Antibiotics: Structure-Activity Relationship for Variations in the Nucleoside Unit

Area of Science:

• Medicinal Chemistry
• Microbiology
• Drug Discovery

Background:

• Muraymycins are nucleoside antibiotics with antibacterial properties.
• They target translocase I (MraY), an essential enzyme in bacterial peptidoglycan synthesis.
• Existing muraymycin analogues have been studied for structure-activity relationships (SAR).

Purpose of the Study:

• To synthesize novel muraymycin analogues with diverse nucleoside units.
• To investigate the impact of structural modifications on MraY inhibitory activity.
• To guide the development of new antibacterial drug candidates.

Main Methods:

• Bipartite synthesis approach to create varied nucleosyl amino acid motifs.
• Incorporation of thymidine- and 5-fluorouridine-derived nucleoside cores.
• In vitro MraY activity assays to evaluate inhibitory potency.

Main Results:

• Substituents at the 5-position of the pyrimidine nucleobase significantly decreased MraY inhibition.
• Loss of nucleobase aromaticity reduced potency approximately tenfold.
• Removal of the 2'-hydroxy group from the ribose moiety retained activity.

Conclusions:

• Specific modifications to the nucleobase negatively impact muraymycin's antibacterial activity.
• The ribose moiety can be modified without compromising MraY inhibition.
• These findings provide crucial SAR insights for designing next-generation muraymycin-based antibiotics.